Accessibility Menu
Bayer Aktiengesellschaft Stock Quote

Bayer Aktiengesellschaft (FRA: BAYN)

$27.56
(0.1%)
+0.02
Price as of October 23, 2025, 6:24 a.m. ET

KEY DATA POINTS

Current Price
€27.56
Daily Change
(0.1%) +$0.02
Day's Range
€27.49 - €27.75
Previous Close
€27.54
Open
€27.5
Beta
0.09
Volume
827
Average Volume
7,632
Market Cap
27.1B
Market Cap / Employee
$27.53M
52wk Range
€18.5 - €29.8
Revenue
-
Gross Margin
0.55%
Dividend Yield
0.40%
EPS
-€3.48
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Bayer Aktiengesellschaft Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BAYN+7.92%-34.82%-8.2%+448%
S&P+14.5%+93.32%+14.09%+1,506%

Bayer Aktiengesellschaft Company Info

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$10.74B-3.6%
Gross Profit$6.38B3.7%
Gross Margin59.36%4.2%
Market Cap$25.15B-2.7%
Market Cap / Employee$0.28M4.9%
Employees89.6K-7.3%
Net Income-$190.00M-630.8%
EBITDA$1.86B-10.4%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$4.56B17.2%
Accounts Receivable$12.88B-4.2%
Inventory12.1K-7.5%

Liabilities

Q2 2025YOY Change
Long Term Debt$31.71B-15.2%
Short Term Debt$6.72B-26.8%

Ratios

Q2 2025YOY Change
Return On Assets-3.04%-2.0%
Return On Invested Capital-5.04%-1.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$125.00M-90.2%
Operating Free Cash Flow$590.00M-69.0%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.830.620.680.786.75%
Price to Sales0.640.410.470.54-1.23%
Price to Tangible Book Value-1.47-0.96-1.07-1.389.64%
Price to Free Cash Flow TTM7.556.335.298.5145.24%
Enterprise Value to EBITDA78.7640.1613.4731.82-4.13%
Free Cash Flow Yield13.2%15.8%18.9%11.8%-31.15%
Return on Equity-2.8%-7.9%-9.6%-10.3%196.87%
Total Debt$41.16B$40.74B$39.39B$38.43B-17.50%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.